Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,087 Dermatology
clinical trials

Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Prurigo Nodularis
Status: Enrolling, Phase II
Updated: 12/31/1969
Study Site 338
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Alphonsus Medical Center-Baker City
mi
from
Baker City, OR
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
OhioHealth Mansfield Hospital
mi
from
Mansfield, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
mi
from
Rolla, MO
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
Geisinger Medical Oncology-Selinsgrove
mi
from
Selinsgrove, PA
Click here to add this to my saved trials
Keratoconus Clinical Trial
Keratoconus Detection by Ultrasound
Status: Enrolling, Phase
Updated: 12/31/1969
London Vision Clinic
mi
from
London,
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling, Phase III
Updated: 4/18/2014
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling, Phase III
Updated: 4/18/2014
Clinical Research Facility
mi
from
Spring Valley, CA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Johnston, RI
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Warren, MI
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 53
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 2/28/2017
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 2/28/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Bellaire, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Berlin, NJ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Newport News, VA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Rogers, AR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Troy, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Trumbull, CT
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Maintaining Lower Levels of Care Through Automated Perineal Hygiene
Status: Enrolling
Updated: 12/31/1969
The Village at Marymount
mi
from
Garfield Heights, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Neurology Clinical Trial
Brentuximab Vedotin for Systemic Sclerosis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Texas Houston Medical School: Division of Rheumatology and Clinical Immunogenetics
mi
from
Houston, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Neurology Clinical Trial
Brentuximab Vedotin for Systemic Sclerosis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Pittsburgh Medical Center: Division of Rheumatology and Clinical
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Rady Children's Hospital - San Diego/University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Dermatology Specialists of Spokane
mi
from
Spokane, WA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Rady Children's Hospital - San Diego/University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Pace Dermatology Associates
mi
from
Tacoma, WA
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Apex Dermatology
mi
from
Denver, CO
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Status: Enrolling, Phase II
Updated: 12/31/1969
AboutSkin Dermatology and DermSurgery
mi
from
Greenwood Village, CO
Click here to add this to my saved trials
Atopic Dermatitis (AD) Clinical Trial
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Brigham and Women's Hospital
mi
from
Foxboro, MA
Click here to add this to my saved trials
Urticaria Clinical Trial
Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)
Status: Enrolling, Phase II
Updated: 12/31/1969
Allergy & Asthma Immunology Associates
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Renaissance Research Medical Group, INC
mi
from
Cape Coral, FL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Innovate Research, LLC
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Forefront Dermatology, S.C.
mi
from
Louisville, KY
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Qualmedica Research
mi
from
Owensboro, KY
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
M3-Wake Research, Inc.
mi
from
Raleigh, NC
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
MediSearch Clinical Trials
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
San Luis Dermatology & Laser Clinic, Inc.
mi
from
San Luis Obispo, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Kirk Barber Research
mi
from
Calgary,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami Dermatology & Laser Research
mi
from
Miami, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Utah MidValley Dematology
mi
from
Murray, UT
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Site 117
mi
from
Belize City,
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miramar, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Calgary,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site 1
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Macon, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Plymouth, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 204
mi
from
Fremont, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 209
mi
from
Fridley, MN
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 371
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 514
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dermatologists of Greater Colombus
mi
from
Bexley, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Revival Research
mi
from
Doral, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Innovate Research, LLC
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
ActivMed Practices & Research, Inc.
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
DMT310-001 Topical in the Treatment of Acne Vulgaris
Status: Enrolling, Phase II
Updated: 12/31/1969
Dermata Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
DMT310-001 Topical in the Treatment of Acne Vulgaris
Status: Enrolling, Phase II
Updated: 12/31/1969
Dermata Investigational Site
mi
from
High Point, NC
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
DMT310-001 Topical in the Treatment of Acne Vulgaris
Status: Enrolling, Phase II
Updated: 12/31/1969
Dermata Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 506
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 365
mi
from
Austin, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 221
mi
from
Bryant, AR
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 524
mi
from
Dublin, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 525
mi
from
Glenn Dale, MD
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 511
mi
from
Knoxville, TN
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 227
mi
from
Omaha, NE
Click here to add this to my saved trials
Lichen Sclerosus Clinical Trial
Biomarkers of Lichen Sclerosus
Status: Enrolling, Phase
Updated: 12/31/1969
The Centers for Vulvovaginal Disorders
mi
from
Washington DC,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanda Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanda Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
1 … 12 13 14 15 16 17 18 19 20 21